Marc Sluijs joined Clipperton in 2023 as Senior Advisor and covers the Digital Health sector. He is based in Geneva, Switzerland.
Through his company Digitalhealth.Network, Marc is advising VC and PE investors such as EQT and Mubadala, Life Sciences companies, as well as various digital health companies such as KAIA Health and Caresyntax. Prior, Marc has spent 20 years working with the Life Sciences industry in a variety of advisory and M&A roles at IQVIA, Accenture, Merck, and Oracle. Marc is also founding advisor to the Digital Therapeutics Alliance and member of the steering committees for Frontiers Health and TechTour Growth Health.
He graduated from Erasmus University Rotterdam with a degree in Business Administration. Subsequently, he followed a variety of executive education programs at IMD, London Business School, and INSEAD.